Incube Ventures Portfolio

BodyMedia is focused on providing clinicians and patients with the most accurate and effective tools for the management of metabolic disorders. The company is the world leader in the design and development of wearable body monitoring products and services.

Corhythm, Inc.

Corhythm is an early stage company developing devices for the treatment of atrial fibrillation.


Entrack Medical, Inc

Entrack is a medical-technology venture developing new solutions for the diagnosis and treatment of gastrointestinal disease.



Fe3 is developing a novel approach for the treatment of iron-deficiency anemia.


Intrapace, Inc.

IntraPace has developed an innovative product platform utilizing gastric stimulation for the treatment of obesity.


Neurolink Medical, Inc.

Neurolink is an early stage company focused on a novel approach for the treatment of epilepsy.


Nfocus is a neurovascular company focused on treating hemorrhagic stroke with a new technology for rapidly treating aneurysms and fistulas in the brain.

Python Medical, Inc

Python is an early stage company developing devices for gastrointestinal surgery.


Rani Therapeutics, LLC

Rani Therapeutics has developed a novel approach for delivering peptides, proteins and antibodies orally. Considered the “holy grail” of drug delivery, Rani has demonstrated greater than 50% oral bioavailability with our Oral Biotherapeutics platform.




Sonoma Orthopedics is developing implants for treating and repairing bone fractures.


Spinal Modulation, Inc.

Spinal Modulation is an early-stage venture creating innovative implantable devices for the management of chronic pain.

  • "Mir and the InCube Ventures team are always ready to support us, and there is no doubt that our relationship has played a key role in our success to date."
    Dave Wood, CEO
    Spinal Modulation
  • "The InCube Ventures team is engaged, and incredibly supportive and willing to help in any way they can to support our success."
    Chris Robins, CEO
    Body Media
  • "InCube Ventures has proven to be enormously helpful to us, especially in the areas of fund raising, corporate discussions and our commercialization strategy."
    Eric Milledge, CEO
    Nfocus Neuromedical
  • "The challenges in bringing an obesity intervention to market are numerous. Mir understands these challenges and has played a fundamental role in helping us to successfully navigate our way to EU approval and commercialization."
    Chuck Brynelsen, CEO
    Intrapace
  • "Our partners at InCube Ventures are helping us make the right decisions that will help us thoughtfully grow our business."
    Glen Coleman, CEO
    Sonoma Orthopedics